Sponsored by IntelliSyn RD
The IntelliSyn Pharma Research Excellence Award (formerly the Boehringer Ingelheim Research Excellence Award) is presented to a scientist residing in Canada who has made a distinguished contribution to medicinally relevant organic or biophysical chemistry while working in Canada. Eligible candidates must have held their first professional appointment as an independent researcher for twelve years* or less at the time of initial nomination.
The 2020 winner of the IntelliSyn Pharma Research Excellence Award is:
Roger G. Linington
Simon Fraser University
Professor Linington received his B.Sc. in Chemistry from the University of Leeds in the UK, his Ph.D. from the University of British Columbia in Vancouver Canada under the supervision of Prof. Raymond Andersen, and postdoctoral work with Prof. William Gerwick at the Scripps Institution of Oceanography at UCSD where he was a participating member of the Panama ICBG project. During this time, he lived and worked in Panama City, Panama, running a semi-independent marine natural products drug discovery program. From 2007 to 2015 he was a faculty member at the University of California Santa Cruz in the Department of Chemistry and Biochemistry. Since 2015 he has been an Associate Professor of Chemistry at Simon Fraser University in Vancouver, Canada where he is also a Tier II Canada Research Chair in High-Throughput Screening and Chemical Biology. He is the recipient of several awards, including the 2014 American Society of Pharmacognosy Matt Suffness Young Investigator award. He has published 78 manuscripts, and his research program focuses on designing new screening and analytical methods for drug discovery and development from natural products.